cover of episode When Hyperkalemia Impairs Optimal Treatment of HF and CKD: What New Guidelines Recommend

When Hyperkalemia Impairs Optimal Treatment of HF and CKD: What New Guidelines Recommend

2023/9/29
logo of podcast Keeping Current

Keeping Current

Shownotes Transcript

Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF).    Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996906?ecd=bdc_podcast_libsyn_mscpedu)